🚀 Exciting news from Shanghai! Chinese researchers at Huashan Hospital, affiliated with Fudan University, have made a groundbreaking discovery in the fight against Parkinson's disease. 🧠✨
Led by Yu Jintai, deputy head of the neurology department, the team has identified FAM171A2 as a new therapeutic target for Parkinson's. This marks the world's first discovery of its kind and was published in the prestigious journal Science on Friday.
After five years of dedicated research, the team didn't stop at just the discovery. They've also found a candidate drug that could potentially slow down the progression of Parkinson's disease, offering hope to millions affected by this condition.
This remarkable research was conducted under the umbrella of the National Center for Neurological Diseases and the National Key Laboratory of Brain Function and Brain Diseases, highlighting the collaborative effort behind this achievement.
Parkinson's is the second most common neurodegenerative disease after Alzheimer's, significantly impacting patients' daily lives. While traditional treatments focus on managing symptoms, this new discovery aims to tackle the disease's progression at its core.
Stay tuned to amigonews.net for more updates on this and other cutting-edge developments in global health! 🌍🔬
Reference(s):
Chinese researchers find new target to treat Parkinson's disease
cgtn.com
